ArticleBMC cancer2021

Histone deacetylase inhibitor panobinostat induces antitumor activity in epithelioid sarcoma and rhabdoid tumor by growth factor receptor modulation.

Anne Catherine Harttrampf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.